BGSF, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BGSF, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2022	FY2024	FY2025
Revenue	254	273	287	220	207	239	298	125	104	93.3
Cost of revenue	194	204	210	150	141	158	195	75.3	66	60
Gross profit	60.1	68.4	76.6	69.8	66	80.9	104	49.8	38.4	33.3
Selling, general and administrative	37.8	44.6	51.1	50.2	55.2	65.1	83.2	45.4	42.9	41.1
Operating income	15.5	17.8	24.3	14.9	-1.23	14.5	16.3	3.07	-5.87	-8.9
Pre-tax income	11.2	14.5	21.4	12.8	-2.81	13.1	14.9	-2.91	-10.8	-13.4
Income tax	4.29	8.66	3.86	4.3	0.51	-3.56	8.47	-2.94	-0.37	-1.28
Income from continuing operations				9.64	-2.07	10.5	11.3	-2.08	-8.7	-11.5
Net income	6.88	5.85	17.5	13.2	1.44	14.1	25.4	-10.2	-3.34	-11.4
EBITDA	22.3	24.1	29.3	19.6	3.63	18.2	20.3	4.38	-4.53	-7.35
EPS, basic	0.85	0.67	1.83	1.29	0.14	1.36	2.43	-0.95	-0.31	-1.04
EPS, diluted	0.82	0.65	1.79	1.28	0.14	1.35	2.42	-0.95	-0.31	-1.04
Shares, basic (weighted)	8.11	8.73	9.58	10.2	10.3	10.4	10.4	10.8	10.9	11
Shares, diluted (weighted)	8.4	9.04	9.81	10.4	10.3	10.4	10.5	10.8	10.9	11
Dividend per share	1.00	1.00	1.15	1.20	0.50	0.44	0.60	0.60	0.15	2.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2022	FY2024	FY2025
Cash and equivalents	0	0	0	0	0	0.11	0	0	0.03	19
Short-term investments										0
Receivables	33.3	36.7	37.6	39.4	32.8	48.1	66.3	29.6	17.1	11.9
Other current assets	0.15	0.14	0.02	0.02	0	2.38	7.46	7.17	2.21	1.46
Total current assets	34.4	38	38.6	40.7	43.6	60.2	76.2	66.9	45.3	38.5
Property, plant and equipment	1.91	2.04	2.56	3.55	3.46	4.33	2.08	1.22	0.61	0.24
Lease right-of-use assets			0	4.39	5.55	3.91	4.46	5.44	1.08	0.63
Goodwill	9.18	18	18	20.2	27.1	29.1	55.2	59.6	1.07	1.07
Intangible assets	23.5	37.3	33	33.8	32.1	33.6	47.6	30.4	4.39	3
Other non-current assets	44.9	64.6	59.1	71.3	1.2	1.28	4.41	5.03	4.07	3
Total assets	81.2	105	100	116	130	148	195	179	150	57.8
Accounts payable	0.95	1.91	0.15	0.48	0.22	0.4	0.59	0.1	0.08	0.5
Accrued liabilities	9.67	11.5	10.4	10.5	10.4	16.2	19.2	14.9	4.87	4.44
Short-term debt	0	2.92	4.24	0.38	2.63	3.56	4	34	3.8	0
Total current liabilities	15.2	21.7	18.1	13.7	18.3	28.4	28.2	85.1	25.9	9.33
Long-term debt	0	20.6	5.77	7.13	26.3	23.3	36	0	32.5	0
Lease liabilities			0	4.13	4.58	2.69	3.05	3.81	0.7	0.3
Other non-current liabilities	0.27	0.45	0.66	0	7.36	3.57	0.01	0
Total liabilities	40.7	65.5	34.6	47.1	64.8	71.7	93.9	93	67.8	9.73
Total debt	0	23.5	10	7.5	28.9	26.9	40	34	36.3	0
Paid-in capital	36.1	37.7	57.6	59.6	60.5	61.9	67	68.6	70.3	71.4
Retained earnings	4.26	1.37	8	8.76	5.05	14.6	33.7	16.9	12	-21.9
Treasury stock							-0	-0	-0	-1.58
Other comprehensive income				0	-0.12	0.06	0
Shareholders' equity	40.5	39.1	65.7	68.5	65.5	76.6	101	85.5	82.3	48.1
Total equity	40.5	39.1	65.7	68.5	65.5	76.6	101	85.5	82.3	48.1
Total liabilities and equity	81.2	105	100	116	130	148	195	179	150	57.8
Shares outstanding	8.67	8.76	10.2	10.3	10.3	0	10.8	10.9	10.9	11.2

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2022	FY2024	FY2025
Net income	6.88	5.85	17.5	13.2	1.44	14.1	25.4	-10.2	-3.34	-11.4
Depreciation and amortization	6.73	6.29	5.04	4.72	4.86	3.7	4.05	1.31	1.33	1.55
Stock-based compensation	0.31	0.45	1.07	0.85	0.79	1.06	1.09	0.96	0.91	1.01
Deferred income tax	-1.1	3.11	1.53	0.8	-2.41	1.28	2.35	-4.21	0.38	-1.65
Change in receivables	-1.39	1.43	-0.94	-2.77	5.03	-15.2	-14.8	-0.82	8.19	3.39
Cash from operations	9.53	18.1	18.4	18	22.3	6.66	-7.12	20.4	24.4	0.14
Capital expenditures	-0.94	-1.15	-0.92	-2.08	-2.08	-3.2	-5.68	-2.15	-1.22	-0.14
Acquisitions	0	-24.5	0	-7.5	-22	-3.79	-33.9	-6.92	0
Cash from investing	-0.93	-25.6	-0.92	-9.73	-24.1	-7.02	-8.92	-9.51	-1.64	91.2
Debt issued	0	25	0	7.5	22.5	0	40	0	4.25	0
Debt repaid	-15.3	-1.11	-13.8	-10.1	-1.08	-2.06	-26.9	-6	-1.7
Stock issued	15.3	0.09	22.2	0.04	-0.01	-0.04	-0	-0.01	0.26	0
Share buybacks								0	0	-1.52
Dividends paid	-8.03	-8.74	-10.9	-12.3	-5.16	-4.57	-6.29	-6.51	-1.64	-22.4
Cash from financing	-8.6	7.58	-17.5	-8.22	1.89	0.47	15.9	-10.9	-22.4	-72.5
Net change in cash	0	0	0	0	0	0.11	-0.11	0	0.35	18.8
Free cash flow	8.59	16.9	17.5	15.9	20.2	3.46	-12.8	18.2	23.2	0
Interest paid	2.44	1.45	1.76	1.35	1.13	0.88	0.64	4.67	4.48	3.27
Income taxes paid	5.5	5.91	2.01	3.56	1	3.68	7.56	1.38	0.69	0.51

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $5.00 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	35.5%	Gross profit / revenue.
Operating margin	-5.9%	Operating income / revenue.
EBITDA margin	-4.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-7.3%	Pre-tax income / revenue.
Net margin	-9.0%	Net income / revenue.
Operating cash flow margin	-3.5%	Cash from operations / revenue.
Return on equity (ROE)	-18.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-15.6%	Net income / average total assets.
Return on invested capital (ROIC)	-11.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	40.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.2%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	1.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-10.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-32.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-14.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-13.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-31.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-12.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-99.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-63.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-100.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-81.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	1,233.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	49.4%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	32.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-41.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-21.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-6.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-61.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-33.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-15.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	5.11x	Current assets / current liabilities.
Quick ratio	4.54x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.74x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	13.0%	Total liabilities / total assets.
Working capital	$27.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	7.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$42.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.74x	Revenue / average total assets.
Fixed asset turnover	356x	Revenue / average property, plant and equipment.
Receivables turnover	7.71x	Revenue / average receivables.
Days sales outstanding	47 days	365 x average receivables / revenue.
Days payables	2 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.84	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$8.70	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.31	Cash from operations / diluted weighted shares.
Book value per share	$4.09	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.75	Tangible book value / shares outstanding.
Cash per share	$1.62	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$53.4M	Share price x shares outstanding.
Enterprise value	$35.1M	Market cap + total debt - cash - short-term investments.
P/S	0.58x	Market cap / revenue.
P/B	1.16x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.26x	Market cap / tangible book value, when positive.
EV/Sales	0.38x	Enterprise value / revenue.
Earnings yield	-15.5%	Net income / market cap (the inverse of P/E).

What was BGSF, INC.'s revenue in fiscal 2025?

BGSF, INC. reported revenue of $93.3M for fiscal 2025, 10.6% lower than the year before.

Was BGSF, INC. profitable in fiscal 2025?

No. It reported a net loss of $11.4M.

How much free cash flow did BGSF, INC. generate in fiscal 2025?

Cash from operations of $142.0K minus capital expenditures of $138.0K left free cash flow of $4.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BGSF, INC.